Syros Pharmaceuticals (SYRS)
(Delayed Data from NSDQ)
$1.62 USD
-0.31 (-15.89%)
Updated Aug 14, 2024 04:00 PM ET
Pre-Market: $1.61 -0.01 (-0.31%) 8:44 AM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.67 | 0.00% |
Earnings Summary
For their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$0.70 per share, beating the Zacks Consensus Estimate of $-0.79 per share. This reflects a positive earnings surprise of 11.39%. Look out for SYRS's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.67 per share, reflecting a year-over-year increase of 50.37%.
Earnings History
Price & Consensus
Zacks News for SYRS
Syros Pharmaceuticals (SYRS) Loses -70.55% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
SYRS: What are Zacks experts saying now?
Zacks Private Portfolio Services